Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

Fig. 7

a-d Documentation of wound healing after treatment with PCMO for the first 16 weeks. After 12 months, improved wound healing was described in all four patients (wound area prior vs. post PCMO application: 21.67 cm2 ± 3.58 vs. 13.27 cm2 ± 3.53 cm2). e-f After 6 months, the angiography revealed increased growth of vascular collaterals (red arrows) in all patients after treatment with PCMO (number of vascular collaterals prior vs. post PCMO application: 8.75 ± 1.71 vs. 13.75 ± 3.30)

Back to article page